Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "excellence"

660 News Found

Natural Biogenex joins forces with Fermbox Bio to boost fermentation-based biomanufacturing
Biotech | March 14, 2026

Natural Biogenex joins forces with Fermbox Bio to boost fermentation-based biomanufacturing

The move comes as the global biotech and biopharma CDMO market continues to surge, fueled by rising demand


India tackles rare diseases head-on at landmark summit in New Delhi
News | March 12, 2026

India tackles rare diseases head-on at landmark summit in New Delhi

Industry leaders highlighted the pharmaceutical sector’s role in advancing research, innovation, early screening, and multi-stakeholder collaboration


KIMS Hospitals makes bold entry into Bengaluru with two new super-speciality units
Hospitals | March 10, 2026

KIMS Hospitals makes bold entry into Bengaluru with two new super-speciality units

The hospitals house over 25 super-speciality centres and Centres of Excellence in Cardiology, Neurology, Oncology, Paediatrics, Orthopaedics, ENT, Obstetrics and Gynaecology, General Surgery, Internal Medicine, Critical Care, and Chronic Disease Management


Lifecore Biomedical teams up with Indomo to advance at-home acne therapy
Biopharma | March 10, 2026

Lifecore Biomedical teams up with Indomo to advance at-home acne therapy

Indomo’s ClearPen system combines a proprietary self-injection device and microneedle with a modernized triamcinolone acetonide formulation


Granules India’s US packaging facility clears FDA inspection with zero observations
Packaging | March 06, 2026

Granules India’s US packaging facility clears FDA inspection with zero observations

The inspection concluded with zero observations, confirming the facility's compliance with current Good Manufacturing Practices


PK Healthcare granted accreditation under 6th edition by NABH
News | March 05, 2026

PK Healthcare granted accreditation under 6th edition by NABH

The 6th Edition NABH framework places strong emphasis on patient safety protocols, robust clinical governance, risk management systems


Lupin receives EIR from FDA for its Goa facility
Drug Approval | February 28, 2026

Lupin receives EIR from FDA for its Goa facility

The EIR was issued following an inspection of the facility from November 10 to November 21, 2025


Sanofi Consumer Healthcare India reports robust Q4 and FY’25 growth
News | February 26, 2026

Sanofi Consumer Healthcare India reports robust Q4 and FY’25 growth

For the fourth quarter, revenue surged 47% year-on-year to Rs. 2,510 million, driven by a 23% rise in domestic sales and a 9.3x jump in export sales